United Kingdom

Showing 1-10 of 35 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Harnessing the glucose lowering actions of alpha-melanocyte stimulatory hormone as a potential new adjunctive therapy for people with type 1 diabetes mellitus	University of Ulster	Alexander Miras	Improving Lives	01-July-2023 to 31-July-2026	$350,884.00
Targeting the chemokine network in insulitis	University of Oxford	Shoumo Bhattacharya	Cures	01-April-2025 to 30-September-2026	$171,799.00
AI-Guided Development of a Vascularized Human Pancreas for In Vitro Type 1 Diabetes Modeling	University of Hull	Amin Ardestani	Cures	01-April-2026 to 31-March-2027	$199,819.00
Are we missing something – do the small things matter?	University of Exeter	Sarah Richardson	Cures	01-May-2025 to 30-April-2028	$994,000.00
Development of a T1DGRS3 for improved multi-ancestry prediction of type 1 diabetes	University of Exeter	Richard Oram	Cures	01-June-2026 to 31-May-2029	$899,463.00
Unlocking the translational potential of extreme forms of autoimmune diabetes by uncovering heterogeneous mechanisms of beta-cell autoimmunity	University of Exeter	Matthew Johnson	Cures	01-April-2024 to 31-March-2029	$335,110.00
Exploring an islet-protective role for native pancreatic mesenchymal stromal cells in health and in type 1 diabetes	University of Exeter	Chloe Rackham	Cures	01-April-2023 to 31-March-2026	$331,643.20
Novel biomarkers for identification of adult-onset Type 1 diabetes	University of Exeter	Angus Jones	Cures	01-January-2026 to 31-December-2027	$898,312.00
Understanding the impact of endogenous insulin secretion on clinical outcomes in type 1 diabetes and the optimal approach to C-peptide measurement for outcome prediction	University of Exeter	Angus Jones	Cures	01-June-2025 to 31-May-2027	$581,477.00
Sotagliflozin in Patients with Heart Failure Symptoms and Type 1 Diabetes (SOPHIST)	University of Dundee	Ify Mordi	Improving Lives	01-September-2023 to 31-August-2027	$1,783,962.00